SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $143,494,671 |
| Positions | 23 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $27,719,273 | 82,796 |
| WHITEHAWK THERAPEUTICS INC | WHWK | COM | $21,461,477 | 4,685,912 |
| TANGO THERAPEUTICS INC | TNGX | COM | $12,221,066 | 390,949 |
| SUTRO BIOPHARMA INC | STRO | COM | $8,972,333 | 270,251 |
| ARRIVENT BIOPHARMA INC | AVBP | COM | $7,597,430 | 218,694 |
| 4D MOLECULAR THERAPEUTICS INC | FDMT | COM | $6,753,753 | 507,801 |
| BRIGHT MINDS BIOSCIENCES INC | DRUG | COM NEW | $6,510,699 | 92,745 |
| OCULAR THERAPEUTIX INC | OCUL | COM | $5,228,963 | 532,481 |
| ERASCA INC | ERAS | COM | $4,858,446 | 265,199 |
| SURROZEN INC | SRZN | COM NEW | $4,499,600 | 173,395 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.